196 related articles for article (PubMed ID: 18174999)
1. Preparation of 2-, 3-, 4- and 7-(2-alkylcarbamoyl-1-alkylvinyl)benzo[b]furans and their BLT1 and/or BLT2 inhibitory activities.
Ando K; Kawamura Y; Akai Y; Kunitomo J; Yokomizo T; Yamashita M; Ohta S; Ohishi T; Ohishi Y
Org Biomol Chem; 2008 Jan; 6(2):296-307. PubMed ID: 18174999
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 2- and 4-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[b]furans having potent antagonistic activity against human leukotriene B4 BLT1 and/or BLT2 receptors.
Ando K; Tsuji E; Ando Y; Kunitomo J; Yamashita M; Ohta S; Nabe T; Kohno S; Yokomizo T; Shimizu T; Ohishi Y
Org Biomol Chem; 2004 Dec; 2(23):3427-31. PubMed ID: 15565232
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 2-, 4- and 5-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[b]furans and their leukotriene B4 receptor antagonistic activity.
Ando K; Tsuji E; Ando Y; Kunitomo J; Kobayashi R; Yokomizo T; Shimizu T; Yamashita M; Ohta S; Nabe T; Kohno S; Ohishi Y
Org Biomol Chem; 2005 Jun; 3(11):2129-39. PubMed ID: 15917901
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis of 2-, 4- and 5-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[b]furans and their leukotriene B4 receptor antagonistic activity].
Ando K
Yakugaku Zasshi; 2005 Nov; 125(11):863-74. PubMed ID: 16272807
[TBL] [Abstract][Full Text] [Related]
5. Preparation of leukotriene B(4) inhibitory active 2- and 3-(2-aminothiazol-4-yl)benzo[b]furan derivatives and their growth inhibitory activity on human pancreatic cancer cells.
Kuramoto M; Sakata Y; Terai K; Kawasaki I; Kunitomo J; Ohishi T; Yokomizo T; Takeda S; Tanaka S; Ohishi Y
Org Biomol Chem; 2008 Aug; 6(15):2772-81. PubMed ID: 18633535
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of novel furo[2,3,4-jk][2]benzazepin-4(3H)-one derivatives.
Ando K; Akai Y; Kunitomo J; Yokomizo T; Nakajima H; Takeuchi T; Yamashita M; Ohta S; Ohishi T; Ohishi Y
Org Biomol Chem; 2007 Feb; 5(4):655-63. PubMed ID: 17285174
[TBL] [Abstract][Full Text] [Related]
7. Preparation of 3-(4-chlorophenyl)-2-(2-aminothiazol-4-yl)-5-methoxybenzo[b]furan derivatives and their leukotriene B(4) inhibitory activity.
Sakata Y; Kuramoto M; Ando K; Yamaguchi M; Kawasaki I; Kunitomo J; Yokomizo T; Ohishi Y
Org Biomol Chem; 2007 Oct; 5(19):3083-6. PubMed ID: 17878965
[TBL] [Abstract][Full Text] [Related]
8. Syntheses of 3-acetoacetylaminobenzo[b]furan derivatives having cysteinyl leukotriene 2 receptor antagonistic activity.
Ando K; Tsuji E; Ando Y; Kuwata N; Kunitomo J; Yamashita M; Ohta S; Kohno S; Ohishi Y
Org Biomol Chem; 2004 Feb; 2(4):625-35. PubMed ID: 14770243
[TBL] [Abstract][Full Text] [Related]
9. Preparation of benzo[b]furans having five-membered heterocycles at the 2-position and 2-(4-Alkylcarbamoylbuta-1,3-dienyl)benzo[b]furans, and their cysteinyl leukotriene receptor (cysLT1, cysLT2) inhibitory activity.
Akai Y; Tabuchi Y; Ando K; Ito A; Sakata Y; Kawasaki I; Ohishi T; Yamashita M; Ohta S; Nishide K; Ohishi Y
Chem Pharm Bull (Tokyo); 2012; 60(11):1461-7. PubMed ID: 23124570
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.
Goodnow RA; Hicks A; Sidduri A; Kowalczyk A; Dominique R; Qiao Q; Lou JP; Gillespie P; Fotouhi N; Tilley J; Cohen N; Choudhry S; Cavallo G; Tannu SA; Ventre JD; Lavelle D; Tare NS; Oh H; Lamb M; Kurylko G; Hamid R; Wright MB; Pamidimukkala A; Egan T; Gubler U; Hoffman AF; Wei X; Li YL; O'Neil J; Marcano R; Pozzani K; Molinaro T; Santiago J; Singer L; Hargaden M; Moore D; Catala AR; Chao LC; Hermann G; Venkat R; Mancebo H; Renzetti LM
J Med Chem; 2010 May; 53(9):3502-16. PubMed ID: 20380377
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis confirms laetirobin as a formal Diels-Alder adduct.
Simon O; Reux B; La Clair JJ; Lear MJ
Chem Asian J; 2010 Feb; 5(2):342-51. PubMed ID: 20033979
[TBL] [Abstract][Full Text] [Related]
13. Blockade of LTB4-induced chemotaxis by bioactive molecules interfering with the BLT2-Galphai interaction.
Kim JY; Lee WK; Yu YG; Kim JH
Biochem Pharmacol; 2010 May; 79(10):1506-15. PubMed ID: 20097180
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis.
Shin EH; Lee HY; Bae YS
Biochem Biophys Res Commun; 2006 Sep; 348(2):606-11. PubMed ID: 16889750
[TBL] [Abstract][Full Text] [Related]
15. Electrophilic cyclization of 2-chalcogenealkynylanisoles: versatile access to 2-chalcogen-benzo[b]furans.
Manarin F; Roehrs JA; Gay RM; Brandão R; Menezes PH; Nogueira CW; Zeni G
J Org Chem; 2009 Mar; 74(5):2153-62. PubMed ID: 19209918
[TBL] [Abstract][Full Text] [Related]
16. Regioselective preparation of benzo[b]furans from phenols and α-bromoketones.
Arias L; Vara Y; Cossío FP
J Org Chem; 2012 Jan; 77(1):266-75. PubMed ID: 22122090
[TBL] [Abstract][Full Text] [Related]
17. Oxidative aromatic C-O bond formation: synthesis of 3-functionalized benzo[b]furans by FeCl3-mediated ring closure of alpha-aryl ketones.
Liang Z; Hou W; Du Y; Zhang Y; Pan Y; Mao D; Zhao K
Org Lett; 2009 Nov; 11(21):4978-81. PubMed ID: 19803501
[TBL] [Abstract][Full Text] [Related]
18. Two distinct leukotriene B4 receptors, BLT1 and BLT2.
Yokomizo T
J Biochem; 2015 Feb; 157(2):65-71. PubMed ID: 25480980
[TBL] [Abstract][Full Text] [Related]
19. Toluene dioxygenase-catalyzed cis-dihydroxylation of benzo[b]thiophenes and benzo[b]furans: synthesis of benzo[b]thiophene 2,3-oxide.
Boyd DR; Sharma ND; Brannigan IN; Evans TA; Haughey SA; McMurray BT; Malone JF; McIntyre PB; Stevenson PJ; Allen CC
Org Biomol Chem; 2012 Sep; 10(36):7292-304. PubMed ID: 22878622
[TBL] [Abstract][Full Text] [Related]
20. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
